Literature DB >> 22776427

Toxoplasmosis in humans and animals in Brazil: high prevalence, high burden of disease, and epidemiology.

J P Dubey1, E G Lago, S M Gennari, C Su, J L Jones.   

Abstract

Infections by the protozoan parasite Toxoplasma gondii are widely prevalent in humans and animals in Brazil. The burden of clinical toxoplasmosis in humans is considered to be very high. The high prevalence and encouragement of the Brazilian Government provides a unique opportunity for international groups to study the epidemiology and control of toxoplasmosis in Brazil. Many early papers on toxoplasmosis in Brazil were published in Portuguese and often not available to scientists in English-speaking countries. In the present paper we review prevalence, clinical spectrum, molecular epidemiology, and control of T. gondii in humans and animals in Brazil. This knowledge should be useful to biologists, public health workers, veterinarians, and physicians. Brazil has a very high rate of T. gondii infection in humans. Up to 50% of elementary school children and 50-80% of women of child-bearing age have antibodies to T. gondii. The risks for uninfected women to acquire toxoplasmosis during pregnancy and fetal transmission are high because the environment is highly contaminated with oocysts. The burden of toxoplasmosis in congenitally infected children is also very high. From limited data on screening of infants for T. gondii IgM at birth, 5-23 children are born infected per 10 000 live births in Brazil. Based on an estimate of 1 infected child per 1000 births, 2649 children with congenital toxoplasmosis are likely to be born annually in Brazil. Most of these infected children are likely to develop symptoms or signs of clinical toxoplasmosis. Among the congenitally infected children whose clinical data are described in this review, several died soon after birth, 35% had neurological disease including hydrocephalus, microcephaly and mental retardation, 80% had ocular lesions, and in one report 40% of children had hearing loss. The severity of clinical toxoplasmosis in Brazilian children may be associated with the genetic characteristics of T. gondii isolates prevailing in animals and humans in Brazil.

Entities:  

Mesh:

Year:  2012        PMID: 22776427     DOI: 10.1017/S0031182012000765

Source DB:  PubMed          Journal:  Parasitology        ISSN: 0031-1820            Impact factor:   3.234


  119 in total

1.  First report of typical Brazilian Toxoplasma gondii genotypes from isolates of free-range chickens (Gallus gallus domesticus) circulating in the state of Paraíba, Northeast Brazil.

Authors:  Thais Ferreira Feitosa; Vinícius Longo Ribeiro Vilela; João Leite de Almeida-Neto; Lídio Ricardo Bezerra de Melo; Dayana Firmino de Morais; Bruna Farias Alves; Fabiana Nakashima; Solange Maria Gennari; Ana Célia Rodrigues Athayde; Hilda Fátima de Jesus Pena
Journal:  Parasitol Res       Date:  2017-06-21       Impact factor: 2.289

Review 2.  The molecular biology and immune control of chronic Toxoplasma gondii infection.

Authors:  Xiao-Yu Zhao; Sarah E Ewald
Journal:  J Clin Invest       Date:  2020-07-01       Impact factor: 14.808

3.  Effects of extracts from Echinacea purpurea (L) MOENCH on mice infected with different strains of Toxoplasma gondii.

Authors:  Arquimedes Gasparotto Junior; Maria Luiza Antonio Cosmo; Michelle de Paula Reis; Pamela Secundo Dos Santos; Daniela Dib Gonçalves; Francielly Mourão Gasparotto; Italmar Teodorico Navarro; Emerson Luiz Botelho Lourenço
Journal:  Parasitol Res       Date:  2016-06-09       Impact factor: 2.289

4.  Toxoplasma genotyping in congenital toxoplasmosis in Upper Egypt: evidence of type I strain.

Authors:  Hanan E M Eldeek; Alzahraa Abdel Raouf Ahmad; Mohamed Ahmed El-Mokhtar; Abdel Rahman M M Abdel Kader; Ahmad M Mandour; Mahmoud Elhady M Mounib
Journal:  Parasitol Res       Date:  2017-07-01       Impact factor: 2.289

Review 5.  Extended-spectrum antiprotozoal bumped kinase inhibitors: A review.

Authors:  Wesley C Van Voorhis; J Stone Doggett; Marilyn Parsons; Matthew A Hulverson; Ryan Choi; Samuel L M Arnold; Michael W Riggs; Andrew Hemphill; Daniel K Howe; Robert H Mealey; Audrey O T Lau; Ethan A Merritt; Dustin J Maly; Erkang Fan; Kayode K Ojo
Journal:  Exp Parasitol       Date:  2017-01-05       Impact factor: 2.011

6.  Genetic and histopathological characterization of Toxoplasma gondii genotypes isolated from free-range chickens reared in the metropolitan region of Rio de Janeiro state, Brazil.

Authors:  Luciana Casartelli-Alves; Sandro Antonio Pereira; Luiz Cláudio Ferreira; Rodrigo de Macedo Couto; Tânia Maria Pacheco Schubach; Maria Regina Reis Amendoeira; Rodrigo Costa da Silva; Hélio Langoni; Patrícia Riddell Millar; Rodrigo Caldas Menezes
Journal:  Parasitol Res       Date:  2021-01-08       Impact factor: 2.289

7.  Sero-epidemiology and risk factors for Toxoplasma gondii among pregnant women in Arab and African countries.

Authors:  Mohamed Alkhatim Alsammani
Journal:  J Parasit Dis       Date:  2014-09-20

8.  Real-time PCR detection of Toxoplasma gondii in surface water samples in São Paulo, Brazil.

Authors:  Ana Tereza Galvani; Ana Paula Guarnieri Christ; José Antonio Padula; Mikaela Renata Funada Barbosa; Ronalda Silva de Araújo; Maria Inês Zanoli Sato; Maria Tereza Pepe Razzolini
Journal:  Parasitol Res       Date:  2019-01-04       Impact factor: 2.289

9.  Identification, production and assessment of two Toxoplasma gondii recombinant proteins for use in a Toxoplasma IgG avidity assay.

Authors:  Ai Ying Teh; Atefeh Amerizadeh; Sabariah Osman; Muhammad Hafiznur Yunus; Rahmah Noordin
Journal:  Pathog Glob Health       Date:  2016-10-04       Impact factor: 2.894

10.  Optimizing small molecule inhibitors of calcium-dependent protein kinase 1 to prevent infection by Toxoplasma gondii.

Authors:  Sebastian Lourido; Chao Zhang; Michael S Lopez; Keliang Tang; Jennifer Barks; Qiuling Wang; Scott A Wildman; Kevan M Shokat; L David Sibley
Journal:  J Med Chem       Date:  2013-03-26       Impact factor: 7.446

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.